MIT Technology Review is reporting that a new documentary about disgraced former biotech CEO Elizabeth Holmes, titled "You Can See Everything," left its reviewer unsettled — not only about Holmes's fraud but about the limits of scientific verification.

The outlet said the film, from filmmakers Nathan Fielder and Lance Oppenheim, documents Holmes and her partner, Billy Evans, at home with their two young children in the weeks before she began serving her prison sentence in May 2023. It said the portrayal is extremely intimate, with Holmes apparently inviting cameras in to reframe her story and present herself as honest. MIT Technology Review said Holmes remains a convincing manipulator, noting that journalists who interviewed her in 2015 later concluded she had lied to them.

The outlet recounted that Holmes dropped out of Stanford University in 2003 at age 19 to run Theranos, which claimed it could run more than 100 diagnostic tests on a few drops of blood. It said the company raised hundreds of millions of dollars and was valued at $9 billion in 2014, and that Forbes named Holmes the youngest self-made female billionaire. MIT Technology Review said a 2015 Wall Street Journal investigation raised concerns that the tests did not work, and that it named Theranos one of the biggest technology failures of 2015. It said Forbes revised Holmes's net worth to $0 in 2016, and that a government report that year found the company's lab struggled with basic procedures and gave patients results that could be wrong. Holmes was sentenced in 2022 to a little over 11 years in prison for defrauding investors.

MIT Technology Review said one early red flag was Theranos's lack of published, peer-reviewed data, with much of its work classified as a trade secret. It said peer review is meant to add rigor, but scientists are not perfect and some exaggerate or manipulate results, citing 10,000 research papers retracted in 2023. The outlet said many researchers now share work on preprint servers that bypass peer review, along with press releases and social media posts.

MIT Technology Review said it would never publish a story about a new scientific development without its own form of peer review, asking trusted scientists what they think of a claim. It said the film is a stark reminder of how easy it is to fall for an appealing narrative, and that everyone should keep interrogating the claims they are given.

Full Article: In the biotech world, you can’t see everything